Skip to main content

Peer Review reports

From: Effectiveness and safety of omalizumab in patients with allergic bronchopulmonary aspergillosis with or without allergic rhinitis: a retrospective chart review

Original Submission
7 May 2023 Submitted Original manuscript
14 Aug 2023 Reviewed Reviewer Report
15 Sep 2023 Reviewed Reviewer Report
21 Sep 2023 Author responded Author comments - Jianying Zhou
Resubmission - Version 2
21 Sep 2023 Submitted Manuscript version 2
Publishing
4 Oct 2023 Editorially accepted
13 Oct 2023 Article published 10.1186/s12890-023-02696-x

You can find further information about peer review here.

Back to article page